EG

Ekta Gupta

Director Director DIN 01564328
DIN 01564328 First appointment Jul 2007 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2007
Shareholding value •••• Premium profile

About Ekta Gupta

Data last updated:

Ekta Gupta was a Director at Lifeline Medicines Private Limited (2007–2009) and Director at Genetech Biotech Private Limited (2008–2018). The companies operate in Trading and Pharma.

DIN 01564328
Primary Designation Director
Industry Trading
First Appointment 13 Jul 2007

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lifeline Medicines Private Limited U24233DL2007PTC165799
Director13 Jul 20072007Active
Genetech Biotech Private Limited U24230DL2008PTC179122
Director05 Jun 20082008₹2.83 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lifeline Medicines Private Limited
Genetech Biotech Private Limited
Premium access

Shareholding and investment profile for Ekta Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ekta Gupta

Ekta Gupta was first appointed on 13 Jul 2007 as Director at Lifeline Medicines Private Limited. The most recent appointment on record is 05 Jun 2008 at Genetech Biotech Private Limited.

Ekta Gupta held 2 earlier board appointments: Lifeline Medicines Private Limited (Director, 13 Jul 2007 to 09 Apr 2009); Genetech Biotech Private Limited (Director, 05 Jun 2008 to 27 May 2018).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available